Abstract

Inflammatory bowel disease (IBD) is a collective term for inflammatory diseases including Crohn’s disease and ulcerative colitis. Toll-like receptor 4 (TLR4) is thought to play a key role in the pathogenesis of IBD. Inhibition of TLR4 has been recognized as an effective target for the treatment of IBD. Many phytochemicals have been shown to have potential as new drugs for the treatment of IBD. This review surveyed the available literature and reports which focused on the in vivo effects of phytochemicals targeting TLR4 in different models of IBD, and clarified the significance of TLR4 as a current therapeutic target for IBD. Based on our review, we have concluded that phytochemicals targeting TLR4 are potentially effective candidates for developing new therapeutic drugs against IBD.

Details

Title
Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease
Author
Dai, Wenbin; Long, Longhai; Wang, Xiaoqiang; Sen, Li; Xu, Houping
Pages
1-10
Section
Review
Publication year
2022
Publication date
2022
Publisher
BioMed Central
ISSN
17498546
e-ISSN
1749-8546
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2666127402
Copyright
© 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.